Completion of a NonExclusive Discount Contract According to Section 130A Paragraph 8 Sgb V for Tocilizumab Atc Code L04ac07 for the Period from November 1St 2023 to October 31St 2025 This announcement serves to conclude drug discount agreements in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentioned under point II11 This does not involve the awarding of public contracts within the meaning of Directive 2014 24 EU or Sections 97 ff GWB Contractual partner kEvery pharmaceutical entrepreneur can become one in accordance with Section 4 Paragraph 18 AMG According to the case law of the ECJ such approval procedures are not necessarily subject to public procurement law since no competition takes place due to the lack of a selection decision The announcement serves as an invitation to voteConclusion of discount contracts with nondispositive conditions that apply equally to all contractual partners including the determination of the discount The contract is concluded by signing the contract documents and submitting the required declarations which must be made to the person named under I3Contact point can be requested Doc Title Pharmaceutical products Contract Type Supplies BKK 24 Town Obernkirchen NUTSCode DE Deutschland Contact Point spectrumK GmbH openhousespectrumkde Tender Notice International Competitive Bidding 5694372023 Germany GT89375328

Germany